Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|June 1, 1994
Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolismT Andersson, J O Miners, M E Veronese, et al.
Pharmacogenetics|April 1, 1993
Tolbutamide hydroxylation in humans: lack of bimodality in 106 healthy subjectsM E Veronese, J O Miners, D L Rees, et al.
The American Journal of Cardiology|July 1, 1985
Value of hepatic computerized tomographic scanning during amiodarone therapyJ Markos, M E Veronese, M R Nicholson, et al.
Clinical Pharmacology and Therapeutics|March 1, 1990
Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizersM E Veronese, J O Miners, D Randles, et al.
Biochemical and Biophysical Research Communications|August 31, 1993
Identification of two human brain aryl sulfotransferase cDNAsX Zhu, M E Veronese, C C Bernard, et al.
Chemico-Biological Interactions|June 1, 1994
Heterologous systems for expression of mammalian sulfotransferasesM E Veronese, W Burgess, D Cruickshank, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1995
Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolismJ O Miners, D L Rees, L Valente, et al.
Biochemical Pharmacology|December 3, 1993
Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniquesW Tassaneeyakul, M E Veronese, D J Birkett, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1990
Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450M E Veronese, M E McManus, P Laupattarakasem, et al.
Biochemical Pharmacology|April 26, 1996
Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxenJ O Miners, S Coulter, R H Tukey, et al.
Pageof 4